---
category: news
title: "SRI International and Exscientia Enter Collaboration to Accelerate Drug Discovery Through Automation and Artificial Intelligence"
excerpt: "Exscientia, a clinical-stage Artificial Intelligence (AI) drug-discovery company and SRI International (SRI), a research center headquartered in Menlo Park, California announced today that the companies have entered into a drug-discovery collaboration agreement to implement a new approach to drug discovery by integrating AI design with automated compound synthesis."
publishedDateTime: 2020-05-05T12:30:00Z
webUrl: "https://markets.businessinsider.com/news/stocks/sri-international-and-exscientia-enter-collaboration-to-accelerate-drug-discovery-through-automation-and-artificial-intelligence-1029165479"
type: article
quality: 18
heat: 18
published: false

provider:
  name: Business Insider
  domain: businessinsider.com
  images:
    - url: "https://insideout.app/ai/assets/images/organizations/businessinsider.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - AI

secured: "ePTmDxQrVGHMRCSwP80zAZ5pk56vcb9dvdJAvWh3bWkHmhy+sUfOjle1WK+iEdyHyj9aWq9r3W1Lad3sEPaz8c7avV3oLxEvZHd1VNTRky1Uo8hVMul/HoWhnUBcmqu7jnb79PU5Jiy2mXztcFjU/K4Fk3WdwPeXVScNF4ZfqT3KHq1kax+ZjAa2gj6WDiT+boMlvVIQQD5neQWB7sZ+rDxRT7Q7MrPUBKT6rmxNd91Vg2qqHA/S0ozlqT4Jjo7NJRxexSVMMJ0iIDGtYmBjeYrt0oS5M3x91GEW1ycg2e3h78DMv73NfLcTIhxenbC9;JTnbKvNE7sIYxkivPb2g7Q=="
---

